skin firmness
Individual maximum · mean +14% · 4 weeks · instrumental · n=10Instrumental firmness increased by 5–23% in the 10 participants. The group-average increase was 14%.
お客様の個人データの管理者は、ポーランド法に基づく有限責任会社 GREEN REPUBLIC SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ(KRS 0001195251、NIP 5273182681、REGON 542764309、登記上の所在地:ul. Marcina Kasprzaka 31/119, 01-234 Warsaw、ポーランド)(以下「管理者」または「当社」)です。GENÉVRY ブランドは、OROTAL Commodities Trading SA(Avenue de Champel 29, 1206 Genève、スイス、UID CHE-264.449.639)が所有しています。
個人データの保護に関するお問い合わせは、[email protected] または [email protected] までご連絡ください。
注文の履行。ご注文時に提供されるデータ(氏名、電子メールアドレス、電話番号、配送先および請求先住所、該当する場合は VAT 番号)は、以下の目的で取り扱われます。
ご注文に関する電話でのご連絡。ご注文時に電話番号をご提供いただいた場合、当社のカスタマーサービス(コールセンター)が、注文の確認、状況または履行の詳細についてお電話でご連絡することがあります。この取扱いの法的根拠は、契約の履行(GDPR 第 6 条第 1 項(b))および円滑な注文処理を確保するという当社の正当な利益(GDPR 第 6 条第 1 項(f))です。
ニュースレターおよびマーケティング。お客様が別途任意の同意を与えた場合、当社は、GENÉVRY 製品、プロモーションおよび新着情報を含む商業的およびマーケティング情報を電子的手段(電子メール)および SMS でお送りするために、お客様の電子メールアドレス、ならびに(ご提供いただき SMS による連絡に同意された場合は)電話番号を取り扱います。この取扱いの法的根拠は、お客様の同意(GDPR 第 6 条第 1 項(a))です。お客様はいつでも同意を撤回することができます。電子メール内の配信停止リンクをクリックする、SMS に「STOP」と返信する、または [email protected] にご連絡ください。同意の撤回は、撤回前に行われた取扱いの適法性に影響を及ぼしません。
アカウントおよびショッピングプロフィール。genevry.com でアカウントを作成された場合、当社は、アカウントの維持および今後のお買い物の利便性向上のため、登録時に提供されたデータおよび注文履歴を GDPR 第 6 条第 1 項(b)に基づき取り扱います。
お客様のデータは、genevry.com の運営において当社と協力する信頼できる事業者に提供されることがあります。特に以下の事業者です。
データの提供先は、欧州経済領域(EEA)外に所在することがあります(例:一部の分析および広告ツールの提供者)。その場合、データの移転は、特に欧州委員会が承認した標準契約条項またはその他 GDPR に定められた仕組みに基づき、適切な保護水準を確保した上で行われます。
お客様には以下の権利があります。
上記の権利を行使するには、[email protected] まで書面(電子メール)にてご連絡ください。
データは、genevry.com におけるお客様の興味関心および購入履歴に基づき、お客様に表示される製品のオファーおよびマーケティングコンテンツを最適化するプロファイリングを含め、自動化された方法で取り扱われることがあります。これらの決定はお客様に法的効果を生じさせるものではなく、消費者としてのお客様の権利に影響を及ぼしません。
当社のウェブサイトはクッキーを使用しています。その一部はストアが正常に機能するために必要なものであり、拒否することはできません。その他のクッキー(分析、機能およびマーケティング用)は、ウェブサイトへの初回訪問時に表示されるクッキーバナーを通じてお客様の同意を得た場合に限り使用します。
「同意する」をクリックすることにより、お客様は、統計、外部提供者が提供するコンテンツとのウェブサイトの連携、お客様に合わせた広告の選択および配信(Google Ads、Meta Pixel および TikTok を通じたものを含む)ならびにこれらの広告の効果分析を目的としたクッキーの使用に同意したことになります。
お客様は、ブラウザの設定または当社ウェブサイトのクッキーバナーにおける同意設定を変更することにより、いつでもクッキーへの同意を撤回することができます。同意の撤回は、撤回前に行われた取扱いの適法性に影響を及ぼしません。
当社が使用するツールの詳細:
データの提供は任意ですが、genevry.com でのご注文およびその履行、ならびに契約の締結には必要です。マーケティング目的でのデータ提供は完全に任意であり、お買い物の可否とは無関係です。
当社は、特に適用法令の変更または提供するサービスの範囲の変更に伴い、本プライバシーポリシーを改定する権利を留保します。プライバシーポリシーの最新版は、常に genevry.com でご覧いただけます。
Ultra-concentrate serumQuantum C5$39.90
Renewing day creamHydrocode A5 Lift$39.90
SPF 50 calming creamAnti-Age NC5$39.90
Advanced night creamNocticode R5$39.90
Facial massage stoneThe Sculpting Gua Sha$27.90
Quantum C5 + Hydrocode A5 · 2 × 30 mlThe Morning Duo$74.90 · Save $4.90
Day cream + night cream · 2 × 30 mlThe Day & Night Duo$74.90 · Save $4.90
Night cream + SPF 50 · 2 × 30 mlThe Night & Light Duo$74.90 · Save $4.90
Complete 24-hour ritual · 4 × 30 mlThe Skin Code Protocol$129.90 · Save $29.70Choose your storefront language and currency.
More languages and currencies are on the way. Shipping country can be selected at checkout.
FIND YOUR FORMULA
THE GENÉVRY CIRCLEJoin our circle. Choose your welcome benefit with your first order.
Filed with the European Patent Office on December 22, 2025. The application describes encapsulated vitamin C alongside copper peptide, growth factors and Zanthalene. Read the original technical description, claims and abstract here.
Patent application, not a granted patent. The document presents the applicant’s technical claims.









Technical document reproduced in full. Administrative forms and private access credentials are excluded from this website.
GENÉVRY / THE STUDY ARCHIVETap a photograph to enlarge it.
Original study photographs, without skin retouching. Individual results vary.
Instrumental firmness increased by 5–23% in the 10 participants. The group-average increase was 14%.
Mean wrinkle length decreased from 2.08 to 1.88 mm. A reduction was recorded in 9 of 10 participants. Silicone replicas, VISIOLINE VL650.
Average increase from baseline; hydration increased in all 10 participants. Corneometer CM 825.
Group-average reduction in wrinkle depth. A reduction was recorded in 9 of 10 participants. VISIOLINE VL650.
The reported group-average improvement in SEsm was 10%. Improvement occurred in 9 of 10 participants; individual improvements ranged from 6% to 19%.
Group-average improvement; elasticity increased in 9 of 10 participants.
Group-average improvement in the measured biomechanical parameter; improvement in 9 of 10 participants.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.
All 10 participants rated deep hydration “very good” after four weeks. This is the proportion of respondents.
Average increase from baseline, measured with Corneometer CM 825. Hydration increased in all 10 participants.
The SEsm smoothing parameter improved by 5–26%; the reported group average was +12%. Visioscan VC 98.
All 10 respondents selected “very good” for the glass-skin effect.
All 10 respondents selected “very good” for radiance and vitality.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.
Average increase from baseline, Corneometer CM 825. All 10 participants recorded increased hydration.
The SEsm smoothing parameter improved by 7–26%; the reported group average was +13%. Visioscan VC 98.
All 10 respondents rated skin radiance “very good”; radiance and vitality also received this rating from all respondents.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.
Average increase from baseline 3 hours after one application to the forearm. Corneometer CM 825. This is a separate protocol from the three-week facial study.
Average increase from baseline after three weeks of regular facial use. Corneometer CM 825.
Average increase from baseline one hour after a single application to the forearm.
Average increase from baseline six hours after a single application to the forearm.
Group-average improvement in the smoothing parameter after three weeks of regular facial use, as reported in the study.
Average reduction in measured melanin within pigmentation spots. This does not mean 7% fewer pigmentation spots.
Group-average instrumental change in skin lightness, as reported in the study.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.


This space is reserved for verified purchaser reviews, with product filters, photographs and the option to sort by the most recent. The first reviews will appear here after launch.

Replace one unit of each matching single product in your bag (or one matching two-product set) with the complete 4-formula ritual. All other quantities stay in your bag.
The new order total is shown in your bag before checkout.
GENÉVRY / DOCUMENTED RESULTSAll 10 participants rated deep hydration “very good” after four weeks. This is the proportion of respondents.
Average increase from baseline, measured with Corneometer CM 825. Hydration increased in all 10 participants.
The SEsm smoothing parameter improved by 5–26%; the reported group average was +12%. Visioscan VC 98.
All 10 respondents selected “very good” for the glass-skin effect.
All 10 respondents selected “very good” for radiance and vitality.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.
Average increase from baseline, Corneometer CM 825. All 10 participants recorded increased hydration.
The SEsm smoothing parameter improved by 7–26%; the reported group average was +13%. Visioscan VC 98.
All 10 respondents rated skin radiance “very good”; radiance and vitality also received this rating from all respondents.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.
Instrumental firmness increased by 5–23% in the 10 participants. The group-average increase was 14%.
Mean wrinkle length decreased from 2.08 to 1.88 mm. A reduction was recorded in 9 of 10 participants. Silicone replicas, VISIOLINE VL650.
Average increase from baseline; hydration increased in all 10 participants. Corneometer CM 825.
Group-average reduction in wrinkle depth. A reduction was recorded in 9 of 10 participants. VISIOLINE VL650.
The reported group-average improvement in SEsm was 10%. Improvement occurred in 9 of 10 participants; individual improvements ranged from 6% to 19%.
Group-average improvement; elasticity increased in 9 of 10 participants.
Group-average improvement in the measured biomechanical parameter; improvement in 9 of 10 participants.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.
Average increase from baseline 3 hours after one application to the forearm. Corneometer CM 825. This is a separate protocol from the three-week facial study.
Average increase from baseline after three weeks of regular facial use. Corneometer CM 825.
Average increase from baseline one hour after a single application to the forearm.
Average increase from baseline six hours after a single application to the forearm.
Group-average improvement in the smoothing parameter after three weeks of regular facial use, as reported in the study.
Average reduction in measured melanin within pigmentation spots. This does not mean 7% fewer pigmentation spots.
Group-average instrumental change in skin lightness, as reported in the study.
Instrumental changes are relative to baseline. “Up to” denotes the best individual result; the group mean is shown alongside it. Self-assessments describe participants’ ratings. Individual results vary.
Campaign material. This is a brand story, not a customer testimonial.
Nocticode R5
Campaign material. This is a brand story, not a customer testimonial.
Hydrocode A5 Lift
Campaign material. This is a brand story, not a customer testimonial.
Hydrocode A5 Lift
Campaign material. This is a brand story, not a customer testimonial.
Nocticode R5The copper-peptide component of the GENÉVRY formulation story.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collectionTHE FORMULATION EDIT / 02Vitamin C shown inside a lipid capsule, alongside copper peptide. The animation illustrates encapsulation schematically.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collectionTHE FORMULATION EDIT / 03An encapsulated retinol component in the Nocticode R5 evening formula.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collectionTHE FORMULATION EDIT / 04A complex included in the brand’s advanced formulation materials.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collectionTHE FORMULATION EDIT / 05Part of the collection’s barrier-care ingredient story.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collectionTHE FORMULATION EDIT / 06The tensor complex described in the brand formulation materials.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collectionTHE FORMULATION EDIT / 07The hydration ingredient in the collection’s formulation palette.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collectionTHE FORMULATION EDIT / 08The antioxidant-care component in the brand formulation materials.
Ingredients differ by product. Consult the individual product INCI before purchase.
Explore the collection